Systemic therapies for malignant pheochromocytoma and paraganglioma can exacerbate hypertension

J Clin Hypertens (Greenwich). 2013 Jul;15(7):513-4. doi: 10.1111/jch.12106. Epub 2013 Apr 11.
No abstract available

Publication types

  • Letter

MeSH terms

  • 3-Iodobenzylguanidine / adverse effects
  • 3-Iodobenzylguanidine / pharmacology
  • Adrenal Gland Neoplasms / drug therapy*
  • Blood Pressure / drug effects
  • Blood Pressure / physiology
  • Disease Management*
  • Drug Therapy
  • Enzyme Inhibitors / adverse effects
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Hypertension / chemically induced
  • Hypertension / epidemiology*
  • Hypertension / physiopathology
  • Paraganglioma / drug therapy*
  • Pheochromocytoma / drug therapy*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Risk Factors

Substances

  • Enzyme Inhibitors
  • 3-Iodobenzylguanidine
  • Protein-Tyrosine Kinases